BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22015738)

  • 21. Prognostic value of lymphangiogenesis in supraglottic laryngeal carcinoma.
    Lin JY; Li XY; Dong P; Nakashima T
    J Laryngol Otol; 2011 Sep; 125(9):945-51. PubMed ID: 21774849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of 6,8-Diprenylgenistein on VEGF-A-Induced Lymphangiogenesis and Lymph Node Metastasis in an Oral Cancer Sentinel Lymph Node Animal Model.
    Bae MG; Hwang-Bo J; Lee DY; Lee YH; Chung IS
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases.
    Wang XL; Fang JP; Tang RY; Chen XM
    BMC Cancer; 2010 Jun; 10():299. PubMed ID: 20565772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer.
    Yang H; Kim C; Kim MJ; Schwendener RA; Alitalo K; Heston W; Kim I; Kim WJ; Koh GY
    Mol Cancer; 2011 Apr; 10():36. PubMed ID: 21481239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-derived VEGF-C, but not VEGF-D, promotes sentinel lymph node lymphangiogenesis prior to metastasis in breast cancer patients.
    Zhao YC; Ni XJ; Wang MH; Zha XM; Zhao Y; Wang S
    Med Oncol; 2012 Dec; 29(4):2594-600. PubMed ID: 22562155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis.
    Eroğlu A; Ersöz C; Karasoy D; Sak S
    Adv Clin Exp Med; 2017; 26(2):245-249. PubMed ID: 28791841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer.
    Schoppmann SF; Tamandl D; Roberts L; Jomrich G; Schoppmann A; Zwrtek R; Dubsky P; Gnant M; Jakesz R; Birner P
    Ann Oncol; 2010 May; 21(5):955-60. PubMed ID: 19940005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative analysis of lymphangiogenic markers for predicting metastasis of human gastric carcinoma to lymph nodes.
    Kitadai Y; Kodama M; Cho S; Kuroda T; Ochiumi T; Kimura S; Tanaka S; Matsumura S; Yasui W; Chayama K
    Int J Cancer; 2005 Jun; 115(3):388-92. PubMed ID: 15688374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor and lymph node lymphangiogenesis--impact on cancer metastasis.
    Tobler NE; Detmar M
    J Leukoc Biol; 2006 Oct; 80(4):691-6. PubMed ID: 16793912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathways targeting tumor lymphangiogenesis.
    Wissmann C; Detmar M
    Clin Cancer Res; 2006 Dec; 12(23):6865-8. PubMed ID: 17145802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymph node lymphangiogenesis: a new concept for modulating tumor metastasis and inflammatory process.
    Ji RC
    Histol Histopathol; 2009 Mar; 24(3):377-84. PubMed ID: 19130407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twist modulates lymphangiogenesis and correlates with lymph node metastasis in supraglottic carcinoma.
    Lu SM; Yu L; Tian JJ; Ma JK; Li JF; Xu W; Wang HB
    Chin Med J (Engl); 2011 May; 124(10):1483-7. PubMed ID: 21740802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Breast Cancer Res Treat; 2005 May; 91(2):125-32. PubMed ID: 15868440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary Tumor-Secreted Lymphangiogenic Factors Induce Pre-Metastatic Lymphvascular Niche Formation at Sentinel Lymph Nodes in Oral Squamous Cell Carcinoma.
    Wakisaka N; Hasegawa Y; Yoshimoto S; Miura K; Shiotani A; Yokoyama J; Sugasawa M; Moriyama-Kita M; Endo K; Yoshizaki T
    PLoS One; 2015; 10(12):e0144056. PubMed ID: 26630663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of lymphangiogenesis through vascular endothelial growth factor-C/vascular endothelial growth factor receptor 3 axis and its correlation with lymph node metastasis in nasopharyngeal carcinoma.
    Wakisaka N; Hirota K; Kondo S; Sawada-Kitamura S; Endo K; Murono S; Yoshizaki T
    Oral Oncol; 2012 Aug; 48(8):703-8. PubMed ID: 22366442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a mouse model for lymph node metastasis with endometrial cancer.
    Takahashi K; Saga Y; Mizukami H; Takei Y; Urabe M; Kume A; Suzuki M; Ozawa K
    Cancer Sci; 2011 Dec; 102(12):2272-7. PubMed ID: 21910784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemokine CCL4 Induces Vascular Endothelial Growth Factor C Expression and Lymphangiogenesis by miR-195-3p in Oral Squamous Cell Carcinoma.
    Lien MY; Tsai HC; Chang AC; Tsai MH; Hua CH; Wang SW; Tang CH
    Front Immunol; 2018; 9():412. PubMed ID: 29599774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IGFBP7 functions as a potential lymphangiogenesis inducer in non-small cell lung carcinoma.
    Zhao W; Wang J; Zhu B; Duan Y; Chen F; Nian W; Sun J; Zhang B; Tong Z; Chen Z
    Oncol Rep; 2016 Mar; 35(3):1483-92. PubMed ID: 26706909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer.
    Patel V; Marsh CA; Dorsam RT; Mikelis CM; Masedunskas A; Amornphimoltham P; Nathan CA; Singh B; Weigert R; Molinolo AA; Gutkind JS
    Cancer Res; 2011 Nov; 71(22):7103-12. PubMed ID: 21975930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.